Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Drugs Form Ternary Complexes with Human Liver Fatty Acid Binding Protein 1 (FABP1) and FABP1 Binding Alters Drug Metabolism

Molecular Pharmacology(2024)10.1124/molpharm.124.000878Source: DataRank Database

Drugs Form Ternary Complexes with Human Liver Fatty Acid Binding Protein 1 (FABP1) and FABP1 Binding Alters Drug Metabolism is a research paper published in Molecular Pharmacology (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.44)OA: hybridTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Alice Martynova,Abhinav Nath ORCID,Benjamin P. Zercher ORCID,Matthew F. Bush ORCID,Nina Isoherranen ORCID

Live enrichment

PubMed:38580446 PMC:PMC11114116 OpenAlex:https://openalex.org/W4393999274

National Science Foundation

Grant: 2203513

Advancing Native Mass Spectrometry for Probing Protein Equilibria and Dynamics

NIDA NIH HHS

Grant: P01 DA032507

NIGMS NIH HHS

Grant: T32 GM007750

National Institutes of Health

Grant: 5P01DA032507-07

Pharmacology of Drugs of Abuse During Pregnancy

National Institutes of Health

Grant: 5T32GM007750-19

DRUG ACTION, METABOLISM AND KINETICS

FWCI

1.44

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

hybridLicense: cc-by-nc

journalhttps://molpharm.aspetjournals.org/content/molpharm/early/2024/04/05/molpharm.124.000878.full.pdf

publisherhttps://molpharm.aspetjournals.org/content/molpharm/early/2024/04/05/molpharm.124.000878.full.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0026895X24001214?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0026895X24001214?httpAccept=text/plain

publisherhttps://syndication.highwire.org/content/doi/10.1124/molpharm.124.000878

Fields of Study

Peroxisome Proliferator-Activated ReceptorsPharmacogenetics and Drug MetabolismReceptor Mechanisms and Signaling03 medical and health sciences0302 clinical medicine

MeSH Terms

Binding SitesDiclofenacPharmaceutical PreparationsHumansLiverOxidation-ReductionProtein BindingFatty Acid-Binding ProteinsCytochrome P-450 CYP2C9

Keywords

Fatty acid-binding proteinPlasma protein bindingDrug metabolismDrugChemistryMetabolismBiochemistryBinding sitePharmacologyBiologyGeneDiclofenacBinding SitesLiverPharmaceutical PreparationsHumansArticlesFatty Acid-Binding ProteinsOxidation-ReductionProtein BindingCytochrome P-450 CYP2C9

Sustainable Development Goals

SDG 0: Good health and well-being

Drugs Form Ternary Complexes with Human Liver Fatty Acid Binding Protein 1 (FABP1) and FABP1 Binding Alters Drug Metabolism

FAIR Checklist

Authors (6)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)